Apple Watch
HRV · 7-day avg
“Why did this drop?”
Pre-seed · raising 2026
Further Health turns the fragmented health data you already have into one private, personalized second opinion.
Decision-support, not diagnosis. Informational only — not medical advice.
A personal note
“I saw eight specialists. None of them could figure out what was going on, until we built our own.
— Zade Kal · Co-founder
Eight specialists, one patient
Blood labs
MRIs
X-rays
No specialist could connect the signals — until we built the system that could.
The problem · fragmentation
Apple Watch
HRV · 7-day avg
“Why did this drop?”
Oura
Sleep score
“Is this normal for me?”
Quest / LabCorp
Ferritin · low
“Should I worry?”
MyChart / Epic
TSH · trending up
“Has it been climbing?”
23andMe
Pharmacogenomics
“Does this affect my Rx?”
Is my HRV crashing because my ferritin dropped?
The data exists. The answer doesn't and the user is the integration layer.
The problem · trust
of Americans say the risks of company data collection outweigh the benefits.
Pew Research
are more worried about data privacy than they were a few years ago.
Pew Research
genetic profiles exposed in the 2023 23andMe breach, then sold in bankruptcy.
SEC filings · 2024
Meanwhile a 15-minute primary-care visit can't see wearable data, can't read trends across panels, and judges every value against a population range — not the patient's own baseline.
Our solution
The only platform that ingests every major class of consumer health data — and synthesizes across them. Competitors specialize in one slice. Further owns the whole stack and runs the analysis primarily on the user's own machine.
The core loop
Ranked hypotheses with confidence levels, supporting evidence drawn from the user's own data, and clear validation paths. Decision-support, not diagnosis.
Product · the “aha” moment
Cross-signal · Apple Watch + Quest · confidence 0.74
Your HRV suppression correlates with low ferritin over the last 90 days. Worth a follow-up panel.
Vitals · last 90 days
Ferritin
↓ 38% · flag
HRV
↓ 11% · watch
TSH
↑ 22% · watch
LDL-C
— · stable
Top hypothesis · Bayesian state · gathering evidence
H-001 · Iron-deficient autonomic stress
conf 0.74Declining ferritin (90d) → reduced O₂ delivery → HRV suppression and rising RHR. Validate with CBC + reticulocytes; consider 100mg ferrous sulfate trial.
Built as a medical aid, not a replacement
Why we win
01 · Storage
Tier 1 holds full PHI, encrypted column-by-column with AES-256-GCM under a KEK/DEK split derived from the user's passphrase. Tier 2 is a one-way pseudonymized mirror — the only surface visible to cloud AI.
02 · Egress
A regex-based firewall with measured 99.92% recall, hardened by clinical BERT and RoBERTa NER models as advisory cross-checks. ML never makes the privacy decision — the gate is deterministic. Any layer detecting PHI hard-blocks.
03 · DNA privacy
Genomes can never be revoked or changed. Further parses your raw file locally and reads only the SNPs needed for analysis. Your raw data is never uploaded, never logged, never shared. Same SNP, same finding, every time.
“The deterministic core is already shipped. KEK/DEK migration, PHI firewall, and the HIF coordinator are all live — engineered, not described.”
Competitive landscape
Capability | WHOOP Advanced Labs Wearables + labs | InsideTracker · Function Lab-centric | 23andMe DNA-centric | Apple Health Distribution | Further Health Synthesis |
|---|---|---|---|---|---|
| Wearables + labs + records + DNA | ~ | ~ | |||
| Cross-signal hypotheses with confidence | ~ | ||||
| Local-first, end-to-end encrypted vault | ~ | ||||
| Deterministic genetic + Rx engine | ~ | ||||
| Action layer · labs · prescriptions | ~ | ||||
| No third-party data brokers | ~ | ~ |
Market opportunity
Wearable units sold annually
and growing double-digit YoY across Apple, Oura, WHOOP, Garmin.
At-home diagnostics market by 2030
Quest, LabCorp, and direct-to-consumer panels expanding into preventative care.
of consumers concerned about how companies use their data
privacy is now a buying criterion, not a soft preference.
The supply side of consumer health data has crossed the chasm. The synthesis layer hasn't.
The market for paying out-of-pocket for clarity (functional medicine, longevity clinics) is already proven.
FTC enforcement against BetterHelp, Flo, and GoodRx has set a new bar. Architectural privacy is no longer optional.
Business model
Phase 01
One-time personal health analysis. High-margin, no infra dependency.
$19.99
Phase 02
Ongoing insights, trend tracking, recurring HIF analysis.
$25–$50 / mo
Phase 03
Concierge service: a dedicated virtual doctor with a set number of visits per year. AI synthesizes every signal so each check-in is fast, evidence-rich, and ready for lab or medication orders.
$100–$300 / mo
Phase 04
Quest, LabCorp, Nucleus, etc. The highest-intent leads in the market.
Affiliate margin per order
Phase 05
HIMS-style telehealth scripts backed by real longitudinal data.
Per-script + recurring
Phase 06
Doctors get higher-quality, longitudinal patient profiles than today's systems can show — with patient consent. Opens the institutional wedge.
Per-seat + per-pull
Phase 07
License the intelligence engine + PHI firewall to clinics and longevity programs.
Enterprise contracts
$19.99
Day-1 SKU
We provide paid analysis on day one. No infrastructure dependency, no scale required to charge. Every later phase compounds on the same vault, the same firewall, the same engine.
Get on the day-1 listTeam
Co-founder & CEO
UC Davis · Neurobiology, Physiology & Behavior · EE + Tech Mgmt minors
Business-development and product operator across fintech, digital assets, and healthcare. Led GTM, partnerships, and integrations for a consumer fintech card at Sophon Labs.
Co-founder & CTO
Washington University in St. Louis · BA Mathematics
AI Engineer at McCarthy Building Companies. Built and scaled a RAG-based Change Order Agent driving 7× the submission volume of top human performers — ~$138K in measured savings.
We're looking for accelerator partners who understand trust, deterministic AI, and category-defining wedges in healthcare.
Reach the team
zade@further.healthWe're talking to investors, accelerator partners, design partners, and people who'd find this useful. If that's you, say hi.